ClinicalTrials.gov
ClinicalTrials.gov Menu

Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00132652
Recruitment Status : Completed
First Posted : August 22, 2005
Last Update Posted : February 23, 2017
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by:
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2006
  Actual Study Completion Date : December 2006